Both the authors contributed equally
Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-Resistant Escherichia coli
Article first published online: 21 MAR 2013
© 2013 John Wiley & Sons A/S
Chemical Biology & Drug Design
Volume 81, Issue 4, pages 484–490, April 2013
How to Cite
Maurya, A., Dwivedi, G. R., Darokar, M. P. and Srivastava, S. K. (2013), Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-Resistant Escherichia coli. Chemical Biology & Drug Design, 81: 484–490. doi: 10.1111/cbdd.12103
- Issue published online: 28 MAR 2013
- Article first published online: 21 MAR 2013
- Accepted manuscript online: 5 JAN 2013 05:19AM EST
- Manuscript Accepted: 10 DEC 2012
- Manuscript Revised: 9 OCT 2012
- Manuscript Received: 8 MAY 2012
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.